Mangoceuticals (NASDAQ: MGRX): A High-Growth Play With Multiple Catalysts
UPDATE 2/12/25: Breaking News: Mangoceuticals Expands Antiviral Research to Combat Avian Flu with Water-Based Solution Dallas, TX – February 12, 2025 – In a groundbreaking development announced this morning, Mangoceuticals, Inc. (NASDAQ: MGRX) is advancing its antiviral research to address the ongoing avian flu crisis in the poultry industry. The company is now testing a […]